STCUBE & CO INC has a total of 40 patent applications. It increased the IP activity by 280.0%. Its first patent ever was published in 2016. It filed its patents most often in China, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are Y CLONE MEDICAL SCIENCES CO LTD, BURIONI ROBERTO and NANJING RONGJIEKANG BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 7 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | Republic of Korea | 6 | |
#5 | United States | 6 | |
#6 | Canada | 3 | |
#7 | Australia | 2 | |
#8 | Japan | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Agriculture | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Animal care | |
#6 | Microorganisms | |
#7 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Yoo Stephen Sunghan | 26 |
#2 | Bong Yong-Sik | 16 |
#3 | Surace Michael Joseph | 12 |
#4 | Lin Steven Hsesheng | 12 |
#5 | Kim Yong-Soo | 12 |
#6 | Chung Ezra Myung Chul | 9 |
#7 | Yoo Stephen S | 7 |
#8 | Sharma Amrish | 6 |
#9 | Hung Mien-Chie | 6 |
#10 | Yoo Stephen | 5 |
Publication | Filing date | Title |
---|---|---|
EP3635007A1 | Methods of treating cancer using antibodies and molecules that bind to btn1a1 or btn1a1-ligands | |
CN111148762A | Antibodies and molecules that immunospecifically bind to BTN1a1 and therapeutic uses thereof | |
KR20200024158A | How to treat cancer using antibodies and molecules that immunospecifically bind to BTN1A1 | |
CN109071636A | Method for selecting the antibody of specific binding glycosylation immunologic test point albumen | |
EP3383911A1 | Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof | |
EP3603651A1 | Screening methods for targets for cancer therapy |